ArticleInternational journal of molecular sciences2024

STAT3 Pathways Contribute to β-HCH Interference with Anticancer Tyrosine Kinase Inhibitors.

Sara Fiorini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.